CPhI China 2010 again “set off†the focus of the global pharmaceutical market
Ten years ago, when the curtain of the first China Pharmaceutical Raw Materials Exhibition (CPhI China 2001) was just opened, it was the beginning of the development of China's pharmaceutical industry as a whole and a major turning point. The rapid growth of the exhibition is rooted in the soil of the increasingly powerful Chinese pharmaceutical industry. After a full decade, not only has it been nurtured to be the “Asia's No. 1 Pharmaceutical Industry Exhibitionâ€, but it has also demonstrated the development, transformation and maturation of companies and even the industry.
Together to help each other, joint ventures to tide over development difficulties
It is well known that the past year has experienced untold hardships for pharmaceutical companies and the export situation is not optimistic. The prices of products generally have a certain degree of downward adjustment. Individual species such as penicillins and vitamins have fallen even further. The domestic market has continued to slump. It is undeniable that the entire pharmaceutical industry has entered a relatively slow period of development.
At the same time, at the 9th World Congress on Pharmaceutical Raw Materials China (CPhI China 2009) held in this industry's “low pointâ€, there was a scene in full swing. The thick commercial atmosphere made the entire show acclaim. Successfully closed. According to the statistics after the meeting, the total exhibition area of ​​the exhibition reached 59,100 square meters, an increase of 10% year-on-year, attracting a total of 1,283 well-known enterprises at home and abroad. He Jinchun, manager of the import and export department of Huasheng Pharmaceutical Co., Ltd., said: “Overall, the conference was well organized and basically met the purpose of the exhibition. We were satisfied.†Against the backdrop of the global financial crisis, the number of exhibitors of enterprises has risen instead of showing signs of corporate recognition of the exhibition and highlighting the strong vitality of the Chinese pharmaceutical market.
After the economic crisis era, the company's preferred platform
According to customs statistics, from January to September 2009, the total import and export of medicines and health products in China reached 38.185 billion U.S. dollars, an increase of 4.6% year-on-year. Among them, the export value was 23.534 billion U.S. dollars. As the main force of pharmaceutical exports, Western medicine raw materials, the first three quarters of exports was 12.182 billion US dollars, down 8.54% year-on-year. Compared with the decline in the first two quarters, the decline has now narrowed substantially. From a single month's trend, Western medicine raw material medicine exports in September reached 1.43 billion US dollars, an increase of 9.48%, an increase of 2.14%, stable growth trend. According to Wang Lifeng of Zhejiang Xinhecheng Co., Ltd., “The fourth quarter of 2008 to the first quarter of 2009 was a low point for the company. Undoubtedly, the crisis has passed and the willingness to purchase has been gradually strengthened. From the perspective of product prices, the main products of the market are There is a large gap between the prices in the first quarter of 2008, but recent trends are gradually picking up."
The pharmaceutical economy has bottomed out and business opportunities in the recovery have been repeated. Companies are eager to try. As of December 2009, more than 1,200 companies have signed up to participate in the 10th World Pharmaceutical Raw Materials China Show (CPhI China 2010) held at Shanghai New International Expo Center from June 2nd to 4th, 2010. It was the same as last year's total number of exhibitors. Internationally renowned companies such as Dow (Dow) and Evonik Degussa (Evonik Degussa) have come to the forefront, and the domestic industry giants such as Hua Yao, Shi Yao, Ha Yao, Dong Yao, Shang Yao, Hisun, Hua Hai, Hua Wei, Xinhua, Lukang, etc. also all appeared again. Coupled with the enthusiastic participation of small and medium-sized enterprises, the explosive demand has allowed the organizer to expand the exhibition hall. Booth sales reflect the company's confidence in the market, and they also want to show their strength through the exhibition platform and seek business opportunities. Therefore, for the well-known brand exhibition in the industry, the world's pharmaceutical raw materials China Exhibition, its degree of favor is more than ever. Yi Jixin, deputy business manager of Zhejiang Hisun Pharmaceutical Co., Ltd. frankly stated: “CPhI is an international exhibition, and the influence and popularity of CPhI China as an indigenous exhibition in China have been widely recognized. Every year, companies will prepare new products at the exhibition. It will be released during the meeting to meet market demand.†Overall, the international market will not change the demand for China's API market, and a series of new regulations and policies in 2010 will also bring a “new atmosphere†to the industry. Faced with new development opportunities, CPHI China will certainly play a greater role in promoting the pharmaceutical trade and industrial exchanges when the show is about to enter the tenth year.